Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T79664 |
RUNX-IN-1
|
Apoptosis | Apoptosis |
RUNX-IN-1 Compound Conjugate 1) 具有与RUNX结合序列共价结合的特性,能有效抑制RUNX蛋白与其靶位点的相互作用。该化合物能激活p53依赖的细胞凋亡(apoptosis)过程,并能够抑制细胞增殖。此外,RUNX-IN-1在PANC-1异种移植小鼠模型中显示出对肿瘤生长的抑制作用。 | |||
T79665 |
RUNX-IN-2
|
Apoptosis | Apoptosis |
RUNX-IN-2 (Compound Conjugate 3) 具有高度特异性,能与RUNX结合序列共价结合并阻断RUNX蛋白与其靶位点的互动。该化合物能诱导p53依赖性细胞凋亡(apoptosis),抑制细胞增殖,并在PANC-1异种移植小鼠模型中抑制肿瘤生长,显示出高效的烷基化活性。 | |||
T9016 |
AI-10-47
1H-Benzimidazole, 2-(2-pyridinyl)-6-(trifluoromethoxy)-AI-10-47 |
Others | Others |
AI-10-47 (1H-Benzimidazole, 2-(2-pyridinyl)-6-(trifluoromethoxy)-AI-10-47) 是 CBFβ-RUNX 结合的小分子抑制剂(IC50:3.2 μM)。 | |||
T61098 |
RUNX1/ETO tetramerization-IN-1
|
||
RUNX1/ETO tetramerization-IN-1 is a small-molecule inhibitor that specifically targets NHR2 of RUNX1/ETO, effectively inhibiting the tetramerization process. With an EC50 value of 0.25 μM, this compound successfully restores gene expression that has been down-regulated by RUNX1/ETO. Furthermore, RUNX1/ETO tetramerization-IN-1 demonstrates promising anti-leukemic activity by inhibiting the proliferation of SKNO-1 cells dependent on RUNX1/ETO and significantly reducing RUNX1/ETO-associated tumor g... |